Sequel Med Tech, LLC and Senseonics announce availability of twiist Automated Insulin Delivery System to treat Type 1 Diabetes
Sequel Med Tech, LLC, a company developing transformative drug delivery technologies, and Senseonics Holdings, Inc., a medical technology company focused on long-term, implantable Continuous Glucose Monitoring (CGM) systems… read more.
